148 related articles for article (PubMed ID: 16931136)
21. Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells.
Di Francesco P; Lisi A; Rieti S; Manni V; Grimaldi S; Garaci E
Biochem Biophys Res Commun; 1999 Oct; 264(1):33-6. PubMed ID: 10527836
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
23. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
24. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
25. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Epstein-Barr virus gene expression upon phorbol ester and hydroxyurea treatment by real-time quantitative PCR.
Pan YR; Fang CY; Chang YS; Chang HY
Arch Virol; 2005 Apr; 150(4):755-70. PubMed ID: 15785969
[TBL] [Abstract][Full Text] [Related]
27. Transcription of the Epstein-Barr virus lytic cycle activator BZLF-1 during oxidative stress induction.
Lassoued S; Gargouri B; El Feki Ael F; Attia H; Van Pelt J
Biol Trace Elem Res; 2010 Oct; 137(1):13-22. PubMed ID: 19898754
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the expression of the Epstein-Barr virus early gene BFRF1.
Granato M; Farina A; Gonnella R; Santarelli R; Frati L; Faggioni A; Angeloni A
Virology; 2006 Mar; 347(1):109-16. PubMed ID: 16406456
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
33. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
[TBL] [Abstract][Full Text] [Related]
34. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.
Wang P; Day L; Dheekollu J; Lieberman PM
J Virol; 2005 Nov; 79(21):13298-309. PubMed ID: 16227252
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.
Chang FR; Hsieh YC; Chang YF; Lee KH; Wu YC; Chang LK
Antiviral Res; 2010 Mar; 85(3):490-5. PubMed ID: 19969023
[TBL] [Abstract][Full Text] [Related]
36. Architecture of replication compartments formed during Epstein-Barr virus lytic replication.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Shirata N; Tsurumi T
J Virol; 2005 Mar; 79(6):3409-18. PubMed ID: 15731235
[TBL] [Abstract][Full Text] [Related]
37. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation.
Yin Q; Jupiter K; Flemington EK
Virology; 2004 Sep; 327(1):134-43. PubMed ID: 15327904
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference.
Chang Y; Chang SS; Lee HH; Doong SL; Takada K; Tsai CH
J Gen Virol; 2004 Jun; 85(Pt 6):1371-1379. PubMed ID: 15166418
[TBL] [Abstract][Full Text] [Related]
40. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
